1. Agyei D, Danquah MK (2011) Industrial-scale manufacturing of pharmaceutical-grade bioactive peptides. Biotechnol Adv 29(3):272–277
2. Ali MAE, Abdel-Fatah OM, Janson JC, Elshafei AM (2012) Antimicrobial potential of Saccharomyces boulardii extracts and fractions. J Appl Sci Res 8(8):4537–4543
3. Bahar AA, Ren D (2013) Antimicrobial Peptides Pharmaceuticals. 6(12):1543–1575. doi: 10.3390/ph6121543
4. Berni Canani R, Cucchiara S, Cuomo R, Pace F, Papale F (2011) Saccharomyces boulardii: a summary of the evidence for gastroenterology clinical practice in adults and children. Eur Rev Med Pharmacol Sci 15(7):809–822
5. Bhunia AK, Johnson MC, Ray B (1988) Purification, characterization and antimicrobial spectrum of a bacteriocin produced by Pediococcus acidilactici. J Appl Microbiol 65(4):261–268